Found: 13
Select item for more details and to access through your institution.
Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 13, p. 1118, doi. 10.1111/hepr.13232
- By:
- Publication type:
- Article
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 2, p. 193, doi. 10.1111/hepr.12916
- By:
- Publication type:
- Article
Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection.
- Published in:
- Hepatology Research, 2017, v. 47, n. 8, p. 767, doi. 10.1111/hepr.12815
- By:
- Publication type:
- Article
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.
- Published in:
- Hepatology Research, 2016, v. 46, n. 12, p. 1256, doi. 10.1111/hepr.12681
- By:
- Publication type:
- Article
Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.
- Published in:
- Hepatology Research, 2016, v. 46, n. 9, p. 944, doi. 10.1111/hepr.12629
- By:
- Publication type:
- Article
Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib.
- Published in:
- Oncology, 2017, v. 92, n. 6, p. 335, doi. 10.1159/000458532
- By:
- Publication type:
- Article
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 3, p. 645, doi. 10.1111/jgh.13511
- By:
- Publication type:
- Article
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0182710
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Digestive Diseases, 2015, v. 16, n. 9, p. 505, doi. 10.1111/1751-2980.12267
- By:
- Publication type:
- Article
Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Advanced liver fibrosis effects on the response to sofosbuvir‐based antiviral therapies for chronic hepatitis C.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 12, p. 1834, doi. 10.1002/jmv.25267
- By:
- Publication type:
- Article